Delix Therapeutics

Drug Discovery · Bedford, MA · Founded 2019 · Privately Held (backing)

Developer of neuroscience therapeutics designed to address mental health and central nervous system conditions. Delix Therapeutics is based in Bedford, MA and was founded in 2019. It was valued at $156 million at a grant in Jun 2024, the last priced event on record. It has raised $109 million across 1 recorded round; the latest was a $70 million Series A in Sep 2021.

PMV mark · valuation
$156.2M
Oct 2026
Priced at
a grant
Jun 2024
Total raised
$108.5M
Last round
Early Stage VC (Series A)
Sep 2021

Who backs Delix Therapeutics?

40 investors
InvestorType
GaingelsVenture capital
RA Capital ManagementAsset manager
Calm VenturesVenture capital
United States Department of War—
Dolby Family VenturesVenture capital
RsquaredVenture capital
Esalen Ventures—
AIC HoldingsFamily office
Talent Resources Ventures—
Casa Verde CapitalVenture capital
+ 30 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Delix Therapeutics investors

40 investors are on record for Delix Therapeutics, including Gaingels, RA Capital Management, Calm Ventures and United States Department of War. By type, the record holds 6 venture capital firms, 3 family offices and 1 asset manager. The Series A in Sep 2021 drew 17 investors.

Free account
More of Delix Therapeutics with a free account
  • ·The complete investor list: 40 names
  • ·Watch Delix Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 40 firms already write checks for companies like Delix Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View